Actieve functies van Mark Lappe
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Efficacy Capital Ltd. | Corporate Officer/Principal | 10-06-2009 | - |
Loopbaan van Mark Lappe
Eerdere bekende functies van Mark Lappe
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INHIBRX, INC. | Algemeen Directeur | 01-04-2010 | 30-05-2024 |
Voorzitter | 01-04-2010 | 30-05-2024 | |
Financieel Directeur/CFO | 01-04-2010 | 01-04-2020 | |
Oprichter | 01-04-2010 | 30-05-2024 | |
President | 01-04-2020 | 30-05-2024 | |
REPROS THERAPEUTICS INC | Voorzitter | 01-01-2008 | 12-11-2009 |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 01-01-2009 | 28-08-2009 |
Efficacy Biotech Fund LP | Oprichter | - | - |
Corporate Officer/Principal | - | - | |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Algemeen Directeur | 01-01-2010 | - |
Oprichter | 01-01-2010 | - | |
Efficacy Capital LLC
Efficacy Capital LLC Investment ManagersFinance Founded in 2004 by Mark Paul Lappe and Jon Faiz Kayyem, Efficacy Capital LLC is a hedge fund manager located in La Jolla, California. The firm provides investment management services primarily to high net-worth individuals. They also manage pooled investment vehicles, including hedge funds and mutual funds | Chief Investment Officer | 03-11-2010 | - |
Oprichter | 03-11-2010 | - | |
Portefeuillebeheerder-Aandelen | 03-11-2010 | - | |
Portfolio Manager-Fixed Income | 25-05-2012 | - | |
Lappe & Associates, Inc. | Oprichter | 19-07-2011 | - |
Corporate Officer/Principal | 10-06-2009 | 19-07-2011 |
Statistieken
Internationaal
Verenigde Staten | 8 |
Verenigd Koninkrijk | 2 |
Operationeel
Founder | 5 |
Chairman | 3 |
Corporate Officer/Principal | 3 |
Sectoraal
Health Technology | 4 |
Health Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INHIBRX, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Efficacy Capital Ltd. | |
Efficacy Biotech Fund LP | |
Osmetech Ltd.
Osmetech Ltd. Medical/Nursing ServicesHealth Services Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom. | Health Services |
Lappe & Associates, Inc. | |
Efficacy Capital LLC
Efficacy Capital LLC Investment ManagersFinance Founded in 2004 by Mark Paul Lappe and Jon Faiz Kayyem, Efficacy Capital LLC is a hedge fund manager located in La Jolla, California. The firm provides investment management services primarily to high net-worth individuals. They also manage pooled investment vehicles, including hedge funds and mutual funds | Finance |
Inhibrx LP
Inhibrx LP BiotechnologyHealth Technology Inhibrx LP developed therapeutic antibodies and pharmaceuticals. Its programs focused on oncology, inflammatory and metabolic diseases and these programs are based on an implementation of multiple antibody and biologic development strategies for therapeutic lead generation, selection, functional enhancement, and optimization. The firm's platforms enabled fit-for-function biotherapeutics that interface with the biology of each target antigen, focus immune activation, and mediate enhanced signaling. The company was founded by Quinn Deveraux, Brendan Eckelman, and Mark Paul Lappe in 2010 and was headquartered in La Jolla, CA. | Health Technology |
- Beurs
- Insiders
- Mark Lappe
- Ervaring